Dysfunctions of Cortical Excitability in Drug-Naïve Posttraumatic Stress Disorder Patients

Biological Psychiatry

Volumn 66, Issue 1, 2009, Pages 54-61

  Rossi, Simone ^a   Capua, Alberto De ^a   Tavanti, Maricla ^a   Calossi, Sara ^a   Polizzotto, Nicola R ^a   Mantovani, Antonio ^a   Falzarano, Vincenzo ^a   Bossini, Letizia ^a   Passero, Stefano ^a   Bartalini, Sabina ^a   Ulivelli, Monica ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

GABA; glutamate; neuroimaging; neurophysiology; PTSD; TMS

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR; GLUTAMIC ACID; ION CHANNEL;

ANXIETY; ARTICLE; AVOIDANCE BEHAVIOR; BRAIN CORTEX; BRAIN DYSFUNCTION; BRAIN FUNCTION; CHOLINERGIC ACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; HEMISPHERE; HUMAN; MENTAL PATIENT; MOTOR CONTROL; NERVE CELL EXCITABILITY; NERVE CELL INHIBITION; NEUROIMAGING; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PROTEIN FUNCTION; SENSORY NERVE; SYMPATHETIC TONE; TRANSCRANIAL MAGNETIC STIMULATION;

ADULT; AGED; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; CEREBRAL CORTEX; ELECTRIC STIMULATION; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; EVOKED POTENTIALS, MOTOR; FEMALE; FUNCTIONAL LATERALITY; HUMANS; MALE; MIDDLE AGED; NEURAL PATHWAYS; REACTION TIME; RETROSPECTIVE STUDIES; SPREADING CORTICAL DEPRESSION; STRESS DISORDERS, POST-TRAUMATIC; TRANSCRANIAL MAGNETIC STIMULATION; TRAUMA SEVERITY INDICES; YOUNG ADULT;

EID: 67349276623     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2009.03.008     Document Type: Article

References (70)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed (1994), American Psychiatric Association, Washington, DC
2. Harvey B.H., Oosthuizen F., Brand L., Wegener G., and Stein D.J. Stress-restress evokes sustained iNOS activity and altered GABA levels and NMDA receptors in rat hippocampus. Psychopharmacology 175 (2004) 494-502
3. A receptor neurotransmission dysfunction in a mouse model of social isolation-induced stress: Possible insights into a non-serotonergic mechanism of action of SSRIs in mood and anxiety disorders. Stress 10 (2007) 3-12
4. Pibiri F., Nelson M., Guidotti A., Costa E., and Pinna G. Decreased corticolimbic allopregnanolone expression during social isolation enhances contextual fear: A model relevant for posttraumatic stress disorder. Proc Natl Acad Sci U S A 105 (2008) 5567-5572
5. A benzodiazepine receptor binding in veterans with post-traumatic stress disorder. Mol Psychiatry 13 (2007) 74-83
6. Bremner J.D., Innis R.B., Southwick S.M., Staib L., Zoghbi S., and Charney D.S. Decreased benzodiazepine receptor binding in prefrontal cortex in combat-related posttraumatic stress disorder. Am J Psychiatry 157 (2000) 1120-1126
7. Fujita M., Southwick S.M., Denucci C.C., Zoghbi S.S., Dillon M.S., Baldwin R.M., et al. Central type benzodiazepine receptors in Gulf War veterans with posttraumatic stress disorder. Biol Psychiatry 56 (2004) 95-100
8. Centonze D., Palmieri M.G., Boffa L., Pierantozzi M., Stanzione P., Brusa L., et al. Cortical hyperexcitability in post traumatic stress disorders secondary to minor accidental head trauma: A neurophysiologic study. J Psychiatry Neurosci 30 (2005) 127-132
9. Nutt D.J. The psychobiology of posttraumatic stress disorders. J Clin Psychol 61 suppl 5 (2000) 24-29
10. Nair J., and Singh A.S. The role of the glutamatergic system in posttraumatic stress disorder. CNS Spectr 13 (2008) 585-591
11. Rossini P.M., Barker A.T., Berardelli A., Caramia M.D., Caruso G., Cracco R.Q., et al. Non-invasive electrical and magnetic stimulation of the brain, spinal cord and roots: Basic principles and procedures for routine clinical application. Report of an IFCN Committee. Electroencephalogr Clin Neurophysiol 91 (1994) 79-92
12. Ziemann U., Lonnecker S., Steinhoff B.J., and Paulus W. The effect of lorazepam on the motor cortical excitability in man. Exp Brain Res 109 (1996) 127-135
13. Ziemann U. TMS and drugs. Clin Neurophysiol 115 (2004) 1717-1729
14. Chen R., Cros D., Currà A., Di Lazzaro V., Lefaucheur J.P., Magistris M.R., et al. The clinical diagnostic utility of transcranial magnetic stimulation: Report of an IFCN Committee. Clin Neurophysiol 119 (2008) 504-532
15. Cantello R., Gianelli M., Civardi C., and Mutani R. Magnetic brain-stimulation: The silent period after the motor evoked-potential. Neurology 42 (1992) 1951-1959
16. Inghilleri M., Berardelli A., Marchetti P., and Manfredi M. Effects of diazepam, baclofen and thiopental on the silent period evoked by transcranial magnetic stimulation in humans. Exp Brain Res 109 (1996) 467-472
17. Siebner H.R., Dressnandt J., Auer C., and Conrad B. Continuous intrathecal baclofen infusions induced a marked increase of the transcranially evoked silent period in a patient with generalized dystonia. Muscle Nerve 21 (1998) 1209-1212
18. Werhahn K.J., Kunesch E., Noachtar S., Benecke R., and Classen J. Differential effects on motorcortical inhibition induced by blockade of GABA uptake in humans. J Physiol Lond 517 (1999) 591-597
19. Di Lazzaro V., Oliviero A., Meglio M., Cioni B., Tamburrini G., Tonali P., et al. Direct demonstration of the effect of lorazepam on the excitability of the human motor cortex. Clin Neurophysiol 111 (2000) 794-799
20. Kujirai T., Caramia M.D., Rothwell J.C., Day B.L., Thompson P.D., Ferbert A., et al. Corticocortical inhibition in human motor cortex. J Physiol 471 (1993) 501-519
21. Ilic T.V., Meintzschel F., Cleff U., Ruge D., Kessler K.R., and Ziemann U. Short interval paired-pulse inhibition and facilitation of human motor cortex: The dimension of stimulus intensity. J Physiol Lond 545 (2002) 153-167
22. Ziemann U., Chen R., Cohen L.G., and Hallett M. Dextromethorphan decreases the excitability of the human motor cortex. Neurology 51 (1998) 320-324
23. Liepert J., Schwenkreis P., Tegenthoff M., and Malin J.P. The glutamate antagonist riluzole suppresses intracortical facilitation. J Neural Transm 104 (1997) 1207-1214
24. Di Lazzaro V., Oliviero A., Profice P., Pennisi M.A., Di Giovanni S., Zito G., et al. Muscarinic receptor blockade has differential effects on the excitability of intracortical circuits in the human motor cortex. Exp Brain Res 135 (2000) 455-461
25. Di Lazzaro V., Oliviero A., Pilato F., Saturno E., Dileone M., Marra C., et al. Neurophysiological predictors of long term response to AChE inhibitors in AD patients. J Neurol Neurosurg Psychiatry 76 (2005) 1064-1069
26. A receptor subtypes: A TMS study. Clin Neurophysiol 118 (2007) 2207-2214
27. Yu M. Recent developments of the PET imaging agents for metabotropic glutamate receptor subtype 5. Curr Top Med Chem 7 (2007) 1800-1805
28. First M.B., Spitzer R.L., Gibbon M., and Williams J.B. Structured Clinical Interview for Axis I DSM-IV Disorders-Patient Edition (SCID-I/P, Version 2.0) (1996), Biometrics Research Department, New York New York State Psychiatric Institute
29. First M.B., Spitzer R.L., Gibbon M., and Williams J.B. Structured Clinical Interview For Axis II DSM IV Disorders (SCID-II/P) (1994), Biometrics Research Department, New York New York State Psychiatric Institute
30. First M.B., Spitzer R.L., Gibbon M., and Williams J.B. Structured Clinical Interview for Axis I DSM IV Disorders, Non-Patient Edition (SCID-I/NP, version 2.0) (1995), Biometrics Research Department, New York New York State Psychiatric Institute
31. Blake D.D., Weathers F.W., Nagy L.M., Kaloupek D.G., Gusman F.D., Charney D.S., et al. The development of a clinician-administered PTSD scale. J Trauma Stress 8 (1995) 75-90
32. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 23 (1960) 56-62
33. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 32 (1959) 50-55
34. Bajibouj M., Lisanby S.H., Lang U.E., Danker-Hopfe H., Heuser I., and Neu P. Evidence for impaired cortical inhibition in patients with unipolar major depression. Biol Psychiatry 59 (2006) 395-400
35. Leafucheur J.P., Lucas B., Andraud F., Hogrel J.Y., Belliver F., Del Cul A., et al. Inter-hemispheric asymmetry of motor corticospinal excitability in major depression studied by transcranial magnetic stimulation. J Psychiatr Res 42 (2008) 389-398
36. Tokimura H., Di Lazzaro V., Tokimura Y., Oliviero A., Profice P., Insola A., et al. Short latency inhibition of human hand motor cortex by somatosensory input from the hand. J Physiol Lond 523 (2000) 503-513
37. Mariorenzi R., Zarola F., Caramia M.D., Paradiso C., and Rossini P.M. Non-invasive evaluation of central motor tract excitability changes following peripheral nerve stimulation in healthy humans. Electroencephalogr Clin Neurophysiol 81 (1991) 90-101
38. Rossini P.M., and Rossi S. Transcranial magnetic stimulation. Diagnostic, therapeutic and research potential. Neurology 68 (2007) 484-488
39. Greenberg B.D., Ziemann U., Corà-Locatelli G., Harmon A., Murphy D.L., Keel J.C., et al. Altered cortical excitability in obsessive-compulsive disorder. Neurology 54 (2000) 142-147
40. Orth M., and Rothwell J. Motor cortex excitability and co-morbidity in Gilles de la Tourette syndrome. J Neurol Neurosurg Psychiatry 80 (2009) 29-34
41. Leafucheur J.P. Motor cortex dysfunction revealed by cortical excitability studies in Parkinson's disease: Influence of antiparkinsonian treatment and cortical stimulation. Clin Neurophysiol 116 (2005) 244-253
42. Rossini P.M., and Dal Forno G. Integrated technology for evaluation of brain function and neural plasticity. Phys Med Rehabil Clin N Am 15 (2004) 263-306
43. Swayne O.B., Rothwell J.C., Ward N.S., and Greenwood R.J. Stages of motor output reorganization after hemispheric stroke suggested by longitudinal studies of cortical physiology. Cereb Cortex 18 (2008) 1909-1922
44. Wassermann E.M., Greenberg B.D., Nguyen M.B., and Murphy D.L. Motor cortex excitability correlates with an anxiety-related personality trait. Biol Psychiatry 50 (2001) 377-382
45. Rossini P.M., Rossi S., Babiloni C., and Polich J. Clinical neurophysiology of aging brain: From normal aging to neurodegeneration. Prog Neurobiol 83 (2007) 375-400
46. Peurala S.H., Müller-Dahlhaus J.F., Arai N., and Ziemann U. Interference of short-interval intracortical inhibition (SICI) and short-interval intracortical facilitation (SICF). Clin Neurophysiol 119 (2008) 2291-2297
47. Kaufer D., Friedman A., Seidman S., and Soreq H. Acute stress facilitates long-lasting changes in cholinergic gene expression. Nature 393 (1998) 373-377
48. Vaiva G., Boss V., Ducrocq F., Fontaine M., Devos P., Brunet A., et al. Relationship between posttrauma GABA plasma levels and PTSD at 1-year follow-up. Am J Psychiatry 163 (2006) 1446-1448
49. Rasmusson A.M., Pinna G., Paliwal P., Weisman D., Gottschalk C., Charney D.S., et al. Decreased cerebrospinal fluid allopregnanolone levels in women with PTSD. Biol Psychiatry 60 (2006) 704-713
50. Vaiva G., Thomas P., Ducrocq F., Fontaine M., Boss V., Devos P., et al. Low posttrauma GABA plasma levels as a predictive factor in the development of acute posttraumatic stress disorder. Biol Psychiatry 55 (2004) 250-254
51. Connor K.M., Davidson J.R., Weisler R.H., Zhang W., and Abraham K. Tiagabine for posttraumatic stress disorder: Effects of open-label and double-blind discontinuation treatment. Psychopharmacology 184 (2006) 21-25
52. Davidson J.R., Brady K., Mellman T.A., Stein M.B., and Pollack M.H. The efficacy and tolerability of tiagabine in adult patients with post-traumatic stress disorder. J Clin Psychopharmacol 27 (2007) 85-88
53. Rauch S.L., van der Kolk B.A., Fisler R.E., Alpert N.M., Orr S.P., Savage C.R., et al. A symptom provocation study using positron emission tomography and script driven imagery. Arch Gen Psychiatry 53 (1996) 380-387
54. Van der Kolk B. The psychobiology of posttraumatic stress disorder. J Clin Psychiatry 58 suppl 9 (1997) 16-24
55. Rossi S., Cappa S.F., Babiloni C., Pasqualetti P., Miniussi C., Carducci F., et al. Prefrontal cortex in long-term memory: An "interference" approach using magnetic stimulation. Nat Neurosci 4 (2001) 948-952
56. Rossi S., Cappa S.F., Ulivelli M., De Capua A., Bartalini S., and Rossini P.M. rTMS for PTSD: Induced merciful oblivion or elimination of abnormal hypermnesia?. Behav Neurol 17 (2006) 195-199
57. Rabe S., Beauducel A., Zöllner T., Maercker A., and Karl A. Regional brain electrical activity in posttraumatic stress disorder after motor vehicle accident. J Abnorm Psychol 115 (2006) 687-698
58. Shankman S.A., Silverstein S.M., Williams L.M., Hopkinson P.J., Kemp A.H., Felmingham K.L., et al. Resting electroencephalogram asymmetry and posttraumatic stress disorder. J Trauma Stress 21 (2008) 190-198
59. Pagani M., Högberg G., Salmaso D., Tärnell B., Sanchez-Crespo A., Soares J., et al. Regional cerebral blood flow during auditory recall in 47 subjects exposed to assaultive and non-assaultive trauma and developing or not posttraumatic stress disorder. Eur Arch Psychiatry Clin Neurosi 255 (2005) 359-365
60. Cohen H., Kaplan Z., Kotler M., Kouperman I., Moisa R., and Grisaru N. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: A double-blind, placebo-controlled study. Am J Psychiatry 161 (2004) 515-524
61. Hertzberg M.A., Butterfield M.I., Feldman M.E., Beckham J.C., Sutherland S.M., Connor K.M., et al. A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder. Biol Psychiatry 45 (1999) 1226-1229
62. Woon F.L., and Hedges D.W. Hippocampal and amygdala volumes in children and adults with childhood maltreatment-related posttraumatic stress disorder: A meta-analysis. Hippocampus 18 (2008) 729-736
63. Bossini L., Tavanti M., Calossi S., Lombardelli A., Polizzotto N.R., Galli R., et al. Magnetic resonance imaging volumes of the hippocampus in drug-naïve patients with post-traumatic stress disorder without comorbidity conditions. J Psychiatr Res 42 (2008) 752-762
64. Vermetten E., Vythilingam M., Southwick S.M., Charney D.S., and Bremner J.D. Long-term treatment with paroxetine increases verbal declarative memory and hippocampal volume in posttraumatic stress disorder. Biol Psychiatry 54 (2003) 693-702
65. Bossini L., Tavanti M., Lombardelli A., Calossi S., Polizzotto N.R., Galli R., et al. Changes in hippocampal volume in patients with post-traumatic stress disorder after sertraline treatment. J Clin Psychopharmacol 27 (2007) 233-235
66. Pitman R.K., Shin L.M., and Rauch S.L. Investigating the pathogenesis of posttraumatic stress disorder with neuroimaging. J Clin Psychiatry 62 (2001) 47-54
67. Bremmer J.D., Elzinga B., Schmahal C., and Vermetten E. Structural and functional plasticity of the human brain in posttraumatic stress disorder. Progr Brain Res 167 (2008) 171-186
68. Ferreri F., Pauri F., Pasqualetti P., Fini R., Dal Forno G., and Rossini P.M. Motor cortex excitability in Alzheimer's disease: A transcranial magnetic stimulation study. Ann Neurol 53 (2003) 102-108
69. Yehuda R., and LeDoux J. Response variation following trauma: A translational neuroscience approach to understanding PTSD. Neuron 56 (2007) 19-32
70. Leafucheur J.P. Principles of therapeutic use of transcranial and epidural cortical stimulation. Clin Neurophysiol 119 (2008) 2179-2184